Symbol Name ID |
Cldn13
claudin 13 MGI:1913102 |
* | Aspects of the system are reported to show a normal phenotype. |
Darker colors indicate more annotations |
Human Phenotypes | Elevated circulating hepatic transaminase concentration |
Diabetes mellitus |
Disease(s) Associated with CLDN4 | ||
pancreatic cancer |
Mouse Phenotypes | homeostasis/metabolism phenotype |
decreased blood urea nitrogen level |
increased circulating bicarbonate level |
decreased fasting circulating glucose level |
increased circulating aldosterone level |
decreased circulating calcium level |
increased circulating potassium level |
increased circulating sodium level |
increased circulating alanine transaminase level |
abnormal renal calcium reabsorption |
decreased circulating chloride level |
increased urine chloride ion level |
abnormal renal sodium reabsorption |
increased urine sodium level |
alkalosis |
increased urine calcium level |
|
Availability | Mouse Genotype | ||||||||||||||||
Cldn4tm1.1Yham/Cldn4tm1.1Yham | * | ||||||||||||||||
Cldn13em1(IMPC)J/Cldn13em1(IMPC)J | |||||||||||||||||
Cldn13tm1.1(KOMP)Vlcg/Cldn13tm1.1(KOMP)Vlcg | |||||||||||||||||
Cldn4tm1.1Jhou/Cldn4tm1.1Jhou Tg(Aqp2-cre)1Dek/0 (conditional) |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/30/2024 MGI 6.23 |
|
|